{"id":3655,"date":"2021-03-09T00:54:15","date_gmt":"2021-03-09T00:54:15","guid":{"rendered":"http:\/\/saniona.com.linux18.curanetserver.dk\/publications\/"},"modified":"2026-04-10T09:38:42","modified_gmt":"2026-04-10T07:38:42","slug":"publikationer-och-presentationer","status":"publish","type":"page","link":"https:\/\/saniona.com\/sv\/vetenskapliga-grund\/publikationer-och-presentationer\/","title":{"rendered":"Publikationer och Presentationer"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; z_index=&#8221;1&#8243; height=&#8221;56vh&#8221; height_tablet=&#8221;45vh&#8221; height_phone=&#8221;70vh&#8221; height_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_fullwidth_slider show_arrows=&#8221;off&#8221; use_bg_overlay=&#8221;off&#8221; admin_label=&#8221;Slider 03&#8243; module_class=&#8221;home-slider-section single-pagebanner&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;56vh&#8221; min_height_tablet=&#8221;45vh&#8221; min_height_phone=&#8221;70vh&#8221; min_height_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; hover_enabled=&#8221;0&#8243; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;17px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; custom_css_slide_description=&#8221;animation-name: none;&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_slide use_bg_overlay=&#8221;off&#8221; use_text_overlay=&#8221;off&#8221; admin_title=&#8221;Slider 01&#8243; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_level=&#8221;h6&#8243; header_font=&#8221;Nunito Sans|600|on||||||&#8221; header_text_color=&#8221;#ffffff&#8221; header_font_size=&#8221;16px&#8221; header_line_height=&#8221;1.1em&#8221; body_font=&#8221;DM Serif Display||||||||&#8221; body_text_color=&#8221;#ffffff&#8221; body_font_size=&#8221;46px&#8221; body_line_height=&#8221;1.3em&#8221; background_enable_color=&#8221;off&#8221; background_image=&#8221;https:\/\/saniona.com\/wp-content\/uploads\/2021\/04\/Journals_B.jpg&#8221; background_enable_image=&#8221;on&#8221; parallax=&#8221;on&#8221; button_alignment=&#8221;left&#8221; width=&#8221;92%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;140px||||false|false&#8221; custom_padding_tablet=&#8221;140px||||false|false&#8221; custom_padding_phone=&#8221;40px||||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; hover_enabled=&#8221;0&#8243; header_text_color_tablet=&#8221;&#8221; header_text_color_phone=&#8221;#555758&#8243; header_text_color_last_edited=&#8221;on|phone&#8221; body_font_size_tablet=&#8221;46px&#8221; body_font_size_phone=&#8221;30px&#8221; body_font_size_last_edited=&#8221;on|tablet&#8221; body_line_height_tablet=&#8221;54px&#8221; body_line_height_phone=&#8221;40px&#8221; body_line_height_last_edited=&#8221;on|tablet&#8221; background_last_edited=&#8221;on|phone&#8221; parallax_phone=&#8221;off&#8221; background_position_phone=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<div class=\"secondary-banner-content\">\n<h6><a href=\"https:\/\/saniona.com\/sv\/vetenskapliga-grund\/\">V\u00c5R VETENSKAPLIGA GRUND<\/a><\/h6>\n<p>Publikationer och Presentationer<\/p>\n<\/div>\n<p>[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; module_class=&#8221;flower-section&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(0,0,0,0)&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;14px||16px||false|false&#8221; custom_padding_tablet=&#8221;&#8221; custom_padding_phone=&#8221;&#8221; box_shadow_style=&#8221;preset3&#8243; box_shadow_vertical=&#8221;-12px&#8221; box_shadow_spread=&#8221;-12px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||5px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/saniona.com\/wp-content\/uploads\/2021\/01\/Saniona_icon_lg_ltblue_new.png&#8221; alt=&#8221;Saniona Icon blue&#8221; title_text=&#8221;Saniona_icon_lg_ltblue_new&#8221; align_tablet=&#8221;&#8221; align_phone=&#8221;&#8221; align_last_edited=&#8221;on|phone&#8221; disabled_on=&#8221;on|off|off&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; z_index=&#8221;-1&#8243; width=&#8221;66%&#8221; width_tablet=&#8221;72%&#8221; width_phone=&#8221;&#8221; width_last_edited=&#8221;on|tablet&#8221; custom_margin=&#8221;-350px||-300px||false|false&#8221; custom_margin_tablet=&#8221;-280px||-300px||false|false&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; animation_style=&#8221;fade&#8221; animation_direction=&#8221;bottom&#8221; animation_duration=&#8221;1400ms&#8221; animation_delay=&#8221;200ms&#8221; scroll_rotating_enable=&#8221;on&#8221; scroll_rotating=&#8221;60|84|84|100|0\u00b0|30\u00b0|90\u00b0&#8221; module_alignment_tablet=&#8221;left&#8221; module_alignment_phone=&#8221;left&#8221; module_alignment_last_edited=&#8221;on|tablet&#8221; scroll_rotating_tablet=&#8221;65|84|84|100|0\u00b0|15\u00b0|90\u00b0&#8221; scroll_rotating_phone=&#8221;&#8221; scroll_rotating_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(0,0,0,0)&#8221; z_index=&#8221;60&#8243; custom_padding=&#8221;16px||60px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;8px|auto||auto||&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;DM Serif Display||||||||&#8221; header_text_color=&#8221;#1d7ecd&#8221; header_font_size=&#8221;44px&#8221; header_line_height=&#8221;1.2em&#8221; header_font_size_tablet=&#8221;38px&#8221; header_font_size_phone=&#8221;32px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Publikationer<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;|15%|32px||false|false&#8221; custom_padding_tablet=&#8221;|0%|||false|false&#8221; custom_padding_phone=&#8221;||80px||false|false&#8221; scroll_vertical_motion=&#8221;0|50|50|100|4|1|0&#8243; scroll_fade=&#8221;0|31|31|100|0|100|100&#8243; motion_trigger_start=&#8221;top&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>December 2024<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Understanding Paralogous Epilepsy-Associated GABAA Receptor Variants: Clinical Implications, Mechanisms, and Potential Pitfalls&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/39642202\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Kan ASH, Kusay AS, Mohammadi NA, Lin SXN, Liao VWY, Lesca G, Souci S, Milh M, Christophersen P, Chebib M, M\u00f8ller RS, Absalom NL, Jensen AA, Ahring PK. Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2413011121. doi: <\/span><a href=\"https:\/\/doi.org\/10.1073\/pnas.2413011121\">10.1073\/pnas.2413011121<\/a><span>. PMID: 39642202<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>August 2024<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Distinct Neurodevelopmental and Epileptic Phenotypes Associated with Gain- and Loss-of-Function GABRB2 Variants&#8221; url=&#8221;https:\/\/www.ean.org\/fileadmin\/user_upload\/ean\/congress-2021\/EAN2021AbstractBook.pdf&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; link_option_url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/38996765\/&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Mohammadi NA, Ahring PK, Liao VWY, Chua HC, Ortiz de la Rosa S, Johannesen KM, Michaeli-Yossef Y, Vincent-Devulder A, Meridda C, Bruel AL, Rossi A, Patel C, Klepper J, Bonanni P, Minghetti S, Trivisano M, Specchio N, Amor D, Auvin S, Baer S, Meyer P, Milh M, Salpietro V, Maroofian R, Lemke JR, Weckhuysen S, Christophersen P, Rubboli G, Chebib M, Jensen AA, Absalom NL, M\u00f8ller RS. EBioMedicine. 2024 Aug;106:105236. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105236\">10.1016\/j.ebiom.2024.105236<\/a><span>. PMID: 38996765<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>December 2023<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;The Shortcoming of Using Glibenclamide in Exploratory Clinical Headache Provocation Studies&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/38064318\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Christophersen P, Dyhring T. Cephalalgia. 2023 Dec;43(12):03331024231219475. doi: <\/span><a href=\"https:\/\/doi.org\/10.1177\/03331024231219475\">10.1177\/03331024231219475<\/a><span>. PMID: 38064318<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>February 2023<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Pharmacological Profiling of KATP Channel Modulators: An Outlook for New Treatment Opportunities for Migraine&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/37259373\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_tablet=&#8221;&#8221; body_font_phone=&#8221;&#8221; body_font_last_edited=&#8221;on|desktop&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Dyhring T, Jansen-Olesen I, Christophersen P, Olesen J. Pharmaceuticals (Basel). 2023 Feb 1;16(2):225. doi: <\/span><a href=\"https:\/\/doi.org\/10.3390\/ph16020225\">10.3390\/ph16020225<\/a><span>. PMID: 37259373<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>September 2022<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Retroviral Glycoprotein-Mediated Immune Suppression via the Potassium Channel KCa3.1 \u2013 A New Strategy for Amelioration of Inflammatory Bowel Diseases&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/35905828\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Laska MJ, Moeller JB, Graversen JH, Str\u00f8b\u00e6k D, Blomster L, Christophersen P, Bahrami S. Clin Immunol. 2022 Sep;242:109081. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.clim.2022.109081\">10.1016\/j.clim.2022.109081<\/a><span>. PMID: 35905828<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>May 2022<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Randomized Controlled Trial of Tesomet for Weight Loss in Hypothalamic Obesity&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/35294397\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Huynh K, Klose M, Krogsgaard K, Drejer J, Byberg S, Madsbad S, Magkos F, Aharaz A, Edsberg B, Tfelt-Hansen J, Astrup AV, Feldt-Rasmussen U. Eur J Endocrinol. 2022 May 9;186(6):687\u2013700. doi: <\/span><a href=\"https:\/\/doi.org\/10.1530\/EJE-21-0972\">10.1530\/EJE-21-0972<\/a><span>. PMID: 35294397<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>October 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Four Phase 1 Trials to Evaluate the Safety and Pharmacokinetic Profile of Single and Repeated Dosing of SCO-101 in Adult Male and Female Volunteers&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/32628359\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Bergmann TK, Stage TB, Stenvang J, Christophersen P, Jacobsen TA, Roest NL, Vestlev PM, Br\u00fcnner N. Basic Clin Pharmacol Toxicol. 2020 Oct;127(4):329\u2013337. doi: <\/span><a href=\"https:\/\/doi.org\/10.1111\/bcpt.13466\">10.1111\/bcpt.13466<\/a><span>. PMID: 32628359<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>April 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Anti-Tremor Action of Subtype Selective Positive Allosteric Modulators of GABAA Receptors in a Rat Model of Essential Tremors&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31989440\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Amrutkar DV, Dyhring T, Jacobsen TA, Larsen JS, Sandager-Nielsen K. Cerebellum. 2020 Apr;19(2):265\u2013274. doi: <\/span><a href=\"https:\/\/doi.org\/10.1007\/s12311-020-01106-w\">10.1007\/s12311-020-01106-w<\/a><span>. PMID: 31989440<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>July 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Expression of \u03b13\u03b22\u03b24 Nicotinic Acetylcholine Receptors by Rat Adrenal Chromaffin Cells Determined Using Novel Conopeptide Antagonists&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31967330\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Hone AJ, Rueda-Ruzafa L, Gordon TJ, Gajewiak J, Christensen S, Dyhring T, Albillos A, McIntosh JM. J Neurochem. 2020 Jul;154(2):158\u2013176. doi: <\/span><a href=\"https:\/\/doi.org\/10.1111\/jnc.14966\">10.1111\/jnc.14966<\/a><span>. PMID: 31967330<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>April 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Characterization of AN6001, a Positive Allosteric Modulator of \u03b16\u03b22-Containing Nicotinic Acetylcholine Receptors&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31887290\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>van Hout M, Klein J, Ahring PK, Brown DT, Thaneshwaran S, Dos Santos AB, Jensen AA, Kohlmeier KA, Christophersen P, Dyhring T. Biochem Pharmacol. 2020 Apr;174:113788. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bcp.2019.113788\">10.1016\/j.bcp.2019.113788<\/a><span>. PMID: 31887290<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>April 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Characterization of AN317, a Novel Selective Agonist of \u03b16\u03b22-Containing Nicotinic Acetylcholine Receptors&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31887288\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Sandager-Nielsen K, Ahring PK, Klein J, van Hout M, Thaneshwaran S, Dos Santos AB, Jacobsen TA, Amrutkar DV, Peters D, Jensen AA, Kohlmeier KA, Christophersen P, Dyhring T. Biochem Pharmacol. 2020 Apr;174:113786. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bcp.2019.113786\">10.1016\/j.bcp.2019.113786<\/a><span>. PMID: 31887288<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>January 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31337271\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Brown BM, Shim H, Christophersen P, Wulff H. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:219\u2013240. doi: <\/span><a href=\"https:\/\/doi.org\/10.1146\/annurev-pharmtox-010919-023420\">10.1146\/annurev-pharmtox-010919-023420<\/a><span>. PMID: 31337271<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>October 2019<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;The Delta-Subunit Selective GABAA Receptor Modulator DS2 Improves Stroke Recovery via an Anti-Inflammatory Mechanism&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31736685\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Neumann S, Boothman-Burrell L, Gowing EK, Jacobsen TA, Ahring PK, Young SL, Sandager-Nielsen K, Clarkson AN. Front Neurosci. 2019 Oct 29;13:1133. doi: <\/span><a href=\"https:\/\/doi.org\/10.3389\/fnins.2019.01133\">10.3389\/fnins.2019.01133<\/a><span>. PMID: 31736685<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>September 2019<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Accurate and Affordable Assessment of Physiological and Pathological Tremor in Rodents Using the Accelerometer of a Smartphone&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/31291169\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Carlsen EMM, Amrutkar DV, Sandager-Nielsen K, Perrier JF. J Neurophysiol. 2019 Sep 1;122(3):970\u2013974. doi: <\/span><a href=\"https:\/\/doi.org\/10.1152\/jn.00281.2019\">10.1152\/jn.00281.2019<\/a><span>. PMID: 31291169<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>May 2019<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Antibodies and Venom Peptides: New Modalities for Ion Channels&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/30728472\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Wulff H, Christophersen P, Colussi P, Chandy KG, Yarov-Yarovoy V. Nat Rev Drug Discov. 2019 May;18(5):339\u2013357. doi: <\/span><a href=\"https:\/\/doi.org\/10.1038\/s41573-019-0013-8\">10.1038\/s41573-019-0013-8<\/a><span>. PMID: 30728472<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>October 2018<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Identification of New Molecular Targets for PET Imaging of the Microglial Anti-Inflammatory Activation State&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/30555554\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Villa A, Klein B, Janssen B, Pedragosa J, Pepe G, Zinnhardt B, Vugts DJ, Gelosa P, Sironi L, Beaino W, Damont A, Doll\u00e9 F, Jego B, Winkeler A, Ory D, Solin O, Vercouillie J, Funke U, Laner-Plamberger S, Blomster LV, Christophersen P, Vegeto E, Aigner L, Jacobs A, Planas AM, Maggi A, Windhorst AD. Theranostics. 2018 Oct;8(19):5400\u20135418. doi: <\/span><a href=\"https:\/\/doi.org\/10.7150\/thno.25572\">10.7150\/thno.25572<\/a><span>. PMID: 30555554<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>July 2017<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Potassium Channel Expression and Function in Microglia: Plasticity and Possible Species Variations&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/28277939\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Nguyen HM, Blomster LV, Christophersen P, Wulff H. Channels (Austin). 2017 Jul;11(4):305\u2013315. doi: <\/span><a href=\"https:\/\/doi.org\/10.1080\/19336950.2017.1300738\">10.1080\/19336950.2017.1300738<\/a><span>. PMID: 28277939<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>February 2017<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Attenuation of Nicotine Taking and Seeking in Rats by the Stoichiometry-Selective Alpha4Beta2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator NS9283&#8243; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/27844094\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Maurer JJ, Sandager-Nielsen K, Schmidt HD. Psychopharmacology (Berl). 2017 Feb;234(3):475\u2013484. doi: <\/span><a href=\"https:\/\/doi.org\/10.1007\/s00213-016-4475-7\">10.1007\/s00213-016-4475-7<\/a><span>. PMID: 27844094<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>December 2016<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Quantification of the Functional Expression of the Ca2+-Activated K+ Channel KCa3.1 on Microglia from Adult Human Neocortical Tissue&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/27470924\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Blomster LV, Str\u00f8baek D, Hougaard C, Klein J, Pinborg LH, Mikkelsen JD, Christophersen P. Glia. 2016 Dec;64(12):2065\u20132078. doi: <\/span><a href=\"https:\/\/doi.org\/10.1002\/glia.23040\">10.1002\/glia.23040<\/a><span>. PMID: 27470924<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>September 2016<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;A Pharmacological Assessment of Agonists and Modulators at \u03b14\u03b22\u03b32 and \u03b14\u03b22\u03b4 GABAA Receptors: The Challenge in Comparing Apples with Oranges&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/27178730\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Ahring PK, Bang LH, Jensen ML, Str\u00f8b\u00e6k D, Hartiadi LY, Chebib M, Absalom N. Pharmacol Res. 2016 Sep;111:563\u2013576. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.014\">10.1016\/j.phrs.2016.05.014<\/a><span>. PMID: 27178730<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>June 2016<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Delineation of the Functional Properties and the Mechanism of Action of TMPPAA, an Allosteric Agonist and Positive Allosteric Modulator of 5-HT3 Receptors&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/27086281\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Gasiorek A, Trattnig SM, Ahring PK, Kristiansen U, Fr\u00f8lund B, Frederiksen K, Jensen AA. Biochem Pharmacol. 2016 Jun 15;110\u2013111:92\u2013108. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bcp.2016.04.004\">10.1016\/j.bcp.2016.04.004<\/a><span>. PMID: 27086281<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>February 2016<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;NS383 Selectively Inhibits Acid-Sensing Ion Channels Containing 1a and 3 Subunits to Reverse Inflammatory and Neuropathic Hyperalgesia in Rats&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/26663905\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Munro G, Christensen JK, Erichsen HK, Dyhring T, Demnitz J, Dam E, Ahring PK. CNS Neurosci Ther. 2016 Feb;22(2):135\u2013145. doi: <\/span><a href=\"https:\/\/doi.org\/10.1111\/cns.12487\">10.1111\/cns.12487<\/a><span>. PMID: 26663905<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>November 2015<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Recent Developments in Ion Channel Pharmacology&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/26646476\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Wulff H, Christophersen P. Channels (Austin). 2015;9(6):335. doi: <\/span><a href=\"https:\/\/doi.org\/10.1080\/19336950.2015.1077650\">10.1080\/19336950.2015.1077650<\/a><span>. PMID: 26646476<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>November 2015<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Pharmacological Gating Modulation of Small- and Intermediate-Conductance Ca2+-Activated K+ Channels (KCa2.x and KCa3.1)&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/26217968\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Christophersen P, Wulff H. Channels (Austin). 2015;9(6):336\u2013343. doi: <\/span><a href=\"https:\/\/doi.org\/10.1080\/19336950.2015.1071748\">10.1080\/19336950.2015.1071748<\/a><span>. PMID: 26217968<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>October 2015<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Acetylcholine-Binding Protein Engineered to Mimic the \u03b14\u2013\u03b14 Binding Pocket in \u03b14\u03b22 Nicotinic Acetylcholine Receptors Reveals Interface-Specific Interactions Important for Binding and Activity&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/26180047\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Shahsavar A, Ahring PK, Olsen JA, Krintel C, Kastrup JS, Balle T, Gajhede M. Mol Pharmacol. 2015 Oct;88(4):697\u2013707. doi: <\/span><a href=\"https:\/\/doi.org\/10.1124\/mol.115.098061\">10.1124\/mol.115.098061<\/a><span>. PMID: 26180047<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>May 2015<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Engineered \u03b14\u03b22 Nicotinic Acetylcholine Receptors as Models for Measuring Agonist Binding and Effect at the Orthosteric Low-Affinity \u03b14\u2013\u03b14 Interface&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/25595102\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Ahring PK, Olsen JA, Nielsen E\u00d8, Peters D, Pedersen MH, Rohde LA, Kastrup JS, Shahsavar A, Indurthi DC, Chebib M, Gajhede M, Balle T. Neuropharmacology. 2015 May;92:135\u2013145. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.12.035\">10.1016\/j.neuropharm.2014.12.035<\/a><span>. PMID: 25595102<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>February 2015<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;GABAA \u03b15 Subunit-Containing Receptors Do Not Contribute to Reversal of Inflammatory-Induced Spinal Sensitization as Indicated by the Unique Selectivity Profile of the GABAA Receptor Allosteric Modulator NS16085&#8243; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/25542996\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>de Lucas AG, Ahring PK, Larsen JS, Rivera-Arconada I, Lopez-Garcia JA, Mirza NR, Munro G. Biochem Pharmacol. 2015 Feb 1;93(3):370\u2013379. doi: <\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bcp.2014.12.010\">10.1016\/j.bcp.2014.12.010<\/a><span>. PMID: 25542996<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>September 2014<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Structural and Functional Studies of the Modulator NS9283 Reveal Agonist-Like Mechanism of Action at \u03b14\u03b22 Nicotinic Acetylcholine Receptors&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/24982426\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Olsen JA, Ahring PK, Kastrup JS, Gajhede M, Balle T. J Biol Chem. 2014 Sep 5;289(36):24911\u201324921. doi: <\/span><a href=\"https:\/\/doi.org\/10.1074\/jbc.M114.568097\">10.1074\/jbc.M114.568097<\/a><span>. PMID: 24982426<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>May 2013<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Anti-Hypertensive Treatment Preserves Appetite Suppression while Preventing Cardiovascular Adverse Effects of Tesofensine in Rats&#8221; url=&#8221;https:\/\/pubmed.ncbi.nlm.nih.gov\/23784901\/&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;15px&#8221; body_line_height=&#8221;1.5em&#8221; custom_padding=&#8221;||||false|false&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Bentzen BH, Grunnet M, Hyveled-Nielsen L, Sundgreen C, Buus Lassen J, Hansen HH. Obesity (Silver Spring). 2013 May;21(5):985\u2013992. doi: <\/span><a href=\"https:\/\/doi.org\/10.1002\/oby.20122\">10.1002\/oby.20122<\/a><span>. PMID: 23784901<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;8px|auto||auto||&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;DM Serif Display||||||||&#8221; header_text_color=&#8221;#1d7ecd&#8221; header_font_size=&#8221;44px&#8221; header_line_height=&#8221;1.2em&#8221; header_font_size_tablet=&#8221;38px&#8221; header_font_size_phone=&#8221;32px&#8221; header_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Posters &amp; Presentationer<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;|15%|32px||false|false&#8221; custom_padding_tablet=&#8221;|0%|||false|false&#8221; custom_padding_phone=&#8221;||80px||false|false&#8221; scroll_vertical_motion=&#8221;0|50|50|100|4|1|0&#8243; scroll_fade=&#8221;0|31|31|100|0|100|100&#8243; motion_trigger_start=&#8221;top&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>October 2025<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Mechanism of Action, Preclinical Efficacy, and Safety Evaluation of ACP-711 (SAN711), a Novel GABAA Subunit \u03b13 Selective Modulator&#8221; url=&#8221;https:\/\/www.businesswire.com\/news\/home\/20251002463817\/en\/Acadia-Pharmaceuticals-Presents-Clinical-Data-from-Across-Multiple-Therapeutic-Programs-at-the-2025-International-Congress-of-Parkinsons-Disease-and-Movement-Disorders&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Amrutkar DV,\u00b9 Sandager-Nielsen K,\u00b9 Dyhring T,\u00b9 Jacobsen TA,\u00b9 Larsen JS,\u00b9 Muglia P,\u00b9 Pathak S,\u00b2 Hofbauer RK.\u00b2 \u00b9Saniona A\/S, Glostrup, Denmark; \u00b2Acadia Pharmaceuticals, Inc., Princeton, NJ, USA. Session OPP9, Abstract LBA9. International Parkinson and Movement Disorder Society\u00ae Congress, Honolulu, Hawaii, October 5\u20139, 2025.<\/p>\n<p>[\/et_pb_blurb][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>November 2023<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Selective Activation of Alpha 3-Containing GABA-A Receptors Blocks Absence Seizures and Increases Sleep Spindles&#8221; url=&#8221;https:\/\/www.sfn.org\/-\/media\/SfN\/Documents\/NEW-SfN\/Meetings\/Neuroscience-2023\/Abstracts\/Abstract-PDFs\/SFN23_Abstracts-PDF-Posters_WED_PM.pdf&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Crunelli V, Morais TP, David F, Atherton Z, Delicata F, Di Giovanni G, Jacobsen TA, Larsen JS, Sandager-Nielsen K. Program No. PSTR526.08. Society for Neuroscience Annual Meeting, Washington D.C., November 2023.<\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>June 2021<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;SAN711, a Selective GABAA \u03b13 Receptor Positive Allosteric Modulator as a Novel Treatment for Trigeminal Neuralgia&#8221; url=&#8221;https:\/\/www.ean.org\/fileadmin\/user_upload\/ean\/congress-2021\/EAN2021AbstractBook.pdf&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Amrutkar DV,\u00b9 Dyhring T,\u00b9 Jacobsen TA,\u00b9 Carson DS,\u00b2 Larsen JS,\u00b9 Sandager-Nielsen K.\u00b9 \u00b9Saniona A\/S, Glostrup, Denmark; \u00b2Saniona, Inc., Waltham, MA, USA. ePresentation EPR-151. European Journal of Neurology 28 (Suppl. 1). 7th Congress of the European Academy of Neurology, virtual, June 19\u201322, 2021.<\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>April 2021<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Comparison of the Novel KCa3.1 Inhibitor SAN903 with Nintedanib and Pirfenidone in a Model of Idiopathic Pulmonary Fibrosis&#8221; url=&#8221;#&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Amrutkar DV,\u00b9 Boddum JK,\u00b9 Jacobsen TA,\u00b9 Carson DS,\u00b2 Brown D,\u00b9 Str\u00f8b\u00e6k D,\u00b9 Christophersen P.\u00b9 \u00b9Saniona A\/S, Glostrup, Denmark; \u00b2Saniona, Inc., Waltham, MA, USA. Abstract ID: L5029. Experimental Biology 2021, April 2021.<\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>September 2020<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;A Randomized-Controlled Trial of Tesomet Resulted in Significant Weight Loss in Hypopituitary Patients with Hypothalamic Obesity&#8221; url=&#8221;https:\/\/www.endocrine-abstracts.org\/ea\/0070\/ea0070aep1073&#8243; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>Huynh K, Klose M, Krogsgaard K, Drejer J, Byberg S, Madsbad S, Magkos F, Aharaz A, Edsberg B, Astrup A, Feldt-Rasmussen U. Endocrine Abstracts. 2020;70:AEP1073. doi: <\/span><a href=\"https:\/\/doi.org\/10.1530\/endoabs.70.AEP1073\">10.1530\/endoabs.70.AEP1073<\/a><span>. European Congress of Endocrinology, virtual, September 5\u20139, 2020.<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>November 2019<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;Tesomet \u2013 A New Treatment Opportunity in Prader-Willi Syndrome: Results from Phase 2a Exploratory Studies in Adult and Adolescent Patients&#8221; url=&#8221;https:\/\/ipwso.org\/wp-content\/uploads\/2020\/11\/IPWSO-10th-International-Conference-booklet.pdf&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Torok D, Kolouskova S, Walter P, Edsberg B, Dvorak R. 10th International Prader-Willi Syndrome Organization Conference, Havana, Cuba, November 13\u201317, 2019. Abstract p. 47.<\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>September 2018<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;SAN711, a Novel GABAA \u03b12\/3 Subtype Selective Positive Allosteric Modulator for Treatment of Neuropathic Pain and Chronic Pruritus&#8221; url=&#8221;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9hdHRhY2htZW50Iiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijg5NjQifX0=@&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _dynamic_attributes=&#8221;url&#8221; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Amrutkar DV, Dyhring T, Jacobsen TA, Larsen JS, Sandager-Nielsen K. Saniona A\/S, Ballerup, Denmark. Poster ID: 471099. IASP World Congress on Pain, Boston, USA, September 2018.<\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>November 2016<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;A New Simple, Automatic and Non-Invasive Method for Measurement of Chemically Induced Tremors in Rats&#8221; url=&#8221;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9hdHRhY2htZW50Iiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijg5NjIifX0=@&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _dynamic_attributes=&#8221;url&#8221; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Amrutkar DV, Jacobsen TA, Sandager-Nielsen K. Saniona A\/S, Ballerup, Denmark. Posterboard No. I28. Society for Neuroscience Annual Meeting, San Diego, USA, November 2016.<\/p>\n<p>[\/et_pb_blurb][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700||on|||||&#8221; text_text_color=&#8221;#ffc13f&#8221; text_font_size=&#8221;15px&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||11px||false|false&#8221; custom_padding=&#8221;20px||||false|false&#8221; border_width_top=&#8221;1px&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;off|desktop&#8221;]<\/p>\n<p>November 2015<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8221;AN363, a Novel GABAA \u03b12\/3\/5 Subtype Selective Positive Allosteric Modulator for Treatment of Chronic Pain&#8221; url=&#8221;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9hdHRhY2htZW50Iiwic2V0dGluZ3MiOnsicG9zdF9pZCI6Ijg5NjMifX0=@&#8221; url_new_window=&#8221;on&#8221; content_max_width=&#8221;1100px&#8221; _builder_version=&#8221;4.27.6&#8243; _dynamic_attributes=&#8221;url&#8221; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700|||||||&#8221; header_font_size=&#8221;20px&#8221; header_line_height=&#8221;1.2em&#8221; body_font_size=&#8221;16px&#8221; body_line_height=&#8221;1.4em&#8221; custom_padding=&#8221;||||false|false&#8221; body_font_size_tablet=&#8221;&#8221; body_font_size_phone=&#8221;15px&#8221; body_font_size_last_edited=&#8221;on|phone&#8221; border_color_top=&#8221;#ffc13f&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Amrutkar DV, Ahring PK, Dyhring T, Nielsen KS, Jacobsen TA, Larsen JS. Posterboard No. I28. Society for Neuroscience Annual Meeting, Chicago, USA, November 2015.<\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>V\u00c5R VETENSKAPLIGA GRUND Publikationer och Presentationer PublikationerDecember 2024Kan ASH, Kusay AS, Mohammadi NA, Lin SXN, Liao VWY, Lesca G, Souci S, Milh M, Christophersen P, Chebib M, M\u00f8ller RS, Absalom NL, Jensen AA, Ahring PK. Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2413011121. doi: 10.1073\/pnas.2413011121. PMID: 39642202August 2024Mohammadi NA, Ahring PK, Liao VWY, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":3001,"parent":3631,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3655","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/pages\/3655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/comments?post=3655"}],"version-history":[{"count":0,"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/pages\/3655\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/pages\/3631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/media\/3001"}],"wp:attachment":[{"href":"https:\/\/saniona.com\/sv\/wp-json\/wp\/v2\/media?parent=3655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}